SIAP
BIIB icon

Sterling Investment Advisors (Pennsylvania)’s Biogen BIIB Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$47K – 419
2019
Q1 		$47K Hold
200
– – 0.02% 211
2018
Q4 		$60K Hold
200
– – 0.04% 178
2018
Q3 		$71K Hold
200
– – 0.04% 186
2018
Q2 		$58K Hold
200
– – 0.03% 195
2018
Q1 		$55K Hold
200
– – 0.03% 188
2017
Q4 		$64K Hold
200
– – 0.04% 167
2017
Q3 		$63K Hold
200
– – 0.04% 158
2017
Q2 		$54K Hold
200
– – 0.04% 175
2017
Q1 		$55K Hold
200
– – 0.04% 169
2016
Q4 		$57K Buy
+200
New +$59.3K 0.05% 147

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s BIIB Position: Q2 2019 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Biogen (BIIB) in Q2 2019, closing a stake of 200 shares — an estimated $47K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in BIIB in Q4 2016 and held it in 10 quarters. The position peaked at $71K in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 200 Biogen shares in Q2 2019, an estimated $47K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Biogen in Q4 2016 and held it in 10 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Biogen position peaked at $71K in Q3 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q2 2019, filed 6 Aug 2019.